Machine learning in classification of AML, aging bone marrow in leukemia, and treating bleeding disorders of unknown cause

Machine learning in classification of AML, ag...

Suivant

New Research: Mitochondrial DNA in TRALI and Venetoclax-Obinituzumab in CLL Trials

In this week's episode, associate editor Dr. James Griffin interviews researchers Dr. John Semple and Dr. Othman Al-Sawaf on their groundbreaking studies on transfusion-related acute lung injury and chronic lymphocytic leukemia treatment. Dr. Semple explored how mitochondrial DNA ...  Afficher plus

Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions

In this week's episode, Blood editor Dr. Laura Michaelis interviews author Dr. Taylor Brooks on his latest paper published in volume 146 issue 18 of Blood Journal. The conversation discusses outcomes of bispecific antibodies (epcoritamab or glofitamab) in treating aggressive B-ce ...  Afficher plus

Épisodes Recommandés

Chronic Leukemias
Ninja Nerd

Ninja Nerds,

Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we explore Chronic Leukemias, focusing on their pathogenesis, clinical features, and modern treatment strategies. We compare Chronic Myeloid Leukemia (CML) and Chronic Lymphocyti ...

  Afficher plus

Acute Leukemias
Ninja Nerd

Ninja Nerds,

Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Acute Leukemias, breaking down their pathophysiology, clinical presentation, and management. We explore the key differences between Acute Myeloid Leukemia (AML) ...

  Afficher plus

Plasma Cell Disorders
Ninja Nerd

Ninja Nerds!

Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we take a closer look at Plasma Cell Disorders, focusing on their pathophysiology, clinical features, and management. Topics include the mechanisms behind multiple myeloma, monoclonal gamm ...

  Afficher plus

Lymphoma
Ninja Nerd

Ninja Nerds,

Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we dive deep into Lymphoma, breaking down its pathogenesis, clinical presentation, and the latest advancements in treatment. We explore the key differences between Hodgkin and No ...

  Afficher plus